9th Advanced GMP Workshop organised: IPA

October 28, 2024

Table of Contents

Last Updated on October 28, 2024 by The Health Master

GMP Workshop

The Indian Pharmaceutical Alliance (IPA) recently hosted its 9th Advanced Good Manufacturing Practices workshop (GMP Workshop), reaffirming its dedication to global manufacturing excellence.

This two-day virtual event brought together over 25 renowned industry leaders, subject matter experts, and global regulatory authorities, including the US Food and Drug Administration (USFDA) and the Central Drugs Standard Control Organization (CDSCO).

Key Takeaways from the GMP Workshop

The GMP workshop was attended by a diverse group of over 2,500 professionals, encompassing C-suite executives from the pharmaceutical industry, academicians, and leaders from prestigious following organizations:

World Health Organization (WHO),
USFDA,
CDSCO,
Indian Generic Pharmaceutical Association (IGBA),
Parenteral Drug Association (PDA),
United States Pharmacopeia (USP), and
other industry associations.

The agenda was packed with insightful sessions covering critical topics and future trends, including:

Strategies for addressing inspection outcomes
Operational excellence
Quality assurance in Bioequivalence (BA)/Bioavailability (BE) studies
Driving regulatory harmonization
Enhancing data governance and sustainability

Click for more Articles on Pharmaceuticals

Click for more Legal Articles on Pharmaceuticals

Industry Leaders Share Insights

The GMP workshop kicked off with a warm welcome address by Sudarshan Jain, Secretary General of IPA.

This was followed by insightful remarks from industry stalwarts:

Dr. Rajeev Raghuvanshi, Drugs Controller General of India, CDSCO, Government of India
Gregory Smith, Country Director, India Office, Office of Global Operations, USFDA
Nilesh Gupta, Chair of the Quality Forum at IPA and Managing Director of Lupin

Dr. Raghuvanshi emphasized the paramount importance of quality in the pharmaceutical industry, stating, “Quality is not just a goal; it’s the bedrock of our global leadership and the trust bestowed upon us.”

“The world increasingly looks to India, not only for generic medicines but also for our growing prominence in advanced areas like biologics, medical devices, and digital health.”

Gupta echoed these sentiments, highlighting the industry’s commitment to quality: “Our reputation and the trust of millions of patients worldwide are built on the foundation of quality.

It’s encouraging to see the Indian pharmaceutical sector making significant strides towards becoming a global quality benchmark through capability building, process improvements, talent development, digitalization, and fostering a quality-first mindset.”

Jain underscored the significance of the 9th Advanced GMP Workshop, stating, “This platform has empowered industry leaders and regulators with the necessary tools and insights to meet the highest international standards.

IPA leadership remains dedicated to strengthening operational capabilities and ensuring that patients worldwide have access to affordable and quality-assured medicines.”

Looking Ahead: 10th Global Pharmaceutical Quality Summit

IPA also announced the dates for its flagship pharma event of the year, the 10th Global Pharmaceutical Quality Summit.

This prestigious event will be held on February 27-28, 2025, in Mumbai.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.